Platform|API|Archive|Contact
Humanexa SignalsPharmaceutical Intelligence
Subscribe
Signals
Regulatory
  • FDA
  • EMA
  • MHRA
  • PMDA
  • Health Canada
Clinical
  • Phase I
  • Phase II
  • Phase III
  • Readouts
  • Enrollment Signals
Competitive
  • Pipeline Tracking
  • Company Moves
  • Asset Intelligence
  • Landscape Reports
Markets
  • Pricing
  • Access
  • Commercial
  • Launch Tracking
M&A Watch
  • Licensing
  • Acquisitions
  • Partnerships
  • Capital Raises
StrategyCatalystsPricing
Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

  • Regulatory
  • Clinical
  • Competitive
  • Markets
  • M&A Watch
  • Strategy
  • Catalyst Tracker

Company

  • Pricing
  • Partner with us
  • Subscribe
  • Contact
  • Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

Intelligence Dataset

Catalyst Tracker

Track upcoming regulatory, clinical, commercial, and strategic events before they impact the market.

228 catalysts

Filters

Pro

Intelligence Pro

Unlock Full Catalyst Intelligence

Access the complete catalyst dataset, advanced filtering, exports, historical events, watchlists, alerts, and API access.

218 additional catalysts available with Intelligence Pro.

Upgrade to Intelligence ProCompare Plans
DateCompanyAssetEvent TypeStatus
July 24, 2026Novitium PharmaPimozideFDA DecisionFDA DecisionPending
July 24, 2026Micro LabsHydrochlorothiazideFDA DecisionFDA DecisionPending
July 25, 2026PfizerHYMPAVZIFDA DecisionFDA DecisionCompleted
July 28, 2026RocheTRUQAPFDA DecisionFDA DecisionCompleted
July 30, 2026LillyOtherCommercial LaunchCommercial LaunchUpcoming
July 31, 2026AstraZenecaTruqapCommercial LaunchCommercial LaunchUpcoming
July 31, 2026AstraZenecaDatrowayFDA DecisionFDA DecisionCompleted
July 31, 2026UnknownRegulatory ApprovalFDA DecisionFDA DecisionUpcoming
July 31, 2026AstraZenecaTruqapFDA DecisionFDA DecisionCompleted
July 31, 2026LillyFoundayoCommercial LaunchCommercial LaunchUpcoming

Intelligence Pro

Unlock Full Catalyst Intelligence

Access the complete catalyst dataset, advanced filtering, exports, historical events, watchlists, alerts, and API access.

218 additional catalysts available with Intelligence Pro.

Upgrade to Intelligence ProCompare Plans
July 31, 2026LillyRegulatory ApprovalFDA DecisionFDA DecisionCompleted
July 31, 2026AstraZenecaSaphneloFDA DecisionFDA DecisionCompleted
July 31, 2026AstraZenecaCamizestrantFDA DecisionFDA DecisionUpcoming
July 31, 2026RocheTrial UpdatePhase II ReadoutPhase II ReadoutUpcoming
August 1, 2026UnknownImmunocoreFDA DecisionFDA DecisionUpcoming

Showing 10 of 228 catalysts

Pagination and full dataset access require Intelligence Pro.

Priority Window

Upcoming 30 Days

Highest-priority catalysts in the next month.

  • 9.0

    AstraZeneca

    Truqap · Commercial Launch

    July 31, 2026

  • 9.0

    AstraZeneca

    Datroway · FDA Decision

    July 31, 2026

  • 8.0

    Pfizer

    HYMPAVZI · FDA Decision

    July 25, 2026

  • 8.0

    Unknown

    Regulatory Approval · FDA Decision

    July 31, 2026

  • 8.0

    Roche

    TRUQAP · FDA Decision

    July 28, 2026

  • 7.0

    Novitium Pharma

    Pimozide · FDA Decision

    July 24, 2026

  • 7.0

    Micro Labs

    Hydrochlorothiazide · FDA Decision

    July 24, 2026

  • 7.0

    Lilly

    Other · Commercial Launch

    July 30, 2026